Annual report pursuant to Section 13 and 15(d)

Investments (Schedule of Equity Method Investment) (Details)

v3.22.4
Investments (Schedule of Equity Method Investment) (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
 Balance Sheets      
Current assets $ 305,232 $ 567,276  
Current liabilities 327,064 288,723  
 Statements of Operations      
Loss from operations (66,024) 40,541 $ 19,441
Net loss (85,480) 12,694 (2,644)
Envestnet’s proportional share of gains (losses) (80,939) 13,296 (3,110)
Equity Method Investments, Total      
 Balance Sheets      
Current assets 42,059 40,333  
Non-current assets 50,703 33,529  
Current liabilities 17,647 20,018  
Non-current liabilities 9,437 1,583  
 Statements of Operations      
Revenues 79,062 65,085 35,603
Loss from operations (8,896) (149) (4,758)
Net loss (7,124) (134) (5,062)
Envestnet’s proportional share of gains (losses) 643 $ (7,093) $ (5,399)
Dilution gain on equity method investee share issuance $ 9,500